Religare Enterprises completed the allotment of 83.43 lakh equity shares after warrant holders paid the remaining amount. This capital infusion of ₹147.05 crore strengthens the company's equity base.
Religare Enterprises has successfully allotted 83,43,263 equity shares following the conversion of warrants. The total capital infused amounts to ₹147.05 crore. Reader Takeaway: Capital infusion via warrant conversion strengthens equity; new shares face lock-in. ## What just happened Religare Enterprises has completed the allotment of 83,43,263 equity shares. This happened after warrant holders paid the remaining 75% of the consideration, bringing the total amount received for these warrants to ₹147.05 crore. The shares were issued at ₹235 each. ## Why this matters This transaction effectively converts debt instruments (warrants) into equity, increasing the company's paid-up equity share capital. It signifies the successful completion of a capital raising exercise and strengthens the company's financial position. ## The backstory This allotment is part of a plan approved by shareholders, where warrants were issued earlier. The conversion process involves warrant holders paying the full consideration, 25% initially and the remaining 75% now. ## What changes now Post-allotment, Religare Enterprises' paid-up equity share capital has increased to ₹341.23 crore, with the total number of shares now at 34,12,33,742. The newly issued shares rank equally with existing ones but are subject to mandatory lock-in periods as per SEBI regulations. ## Risks to watch The primary risk associated with these new shares is the SEBI-prescribed lock-in period, which may restrict their immediate trading by the allottees. ## Peer comparison Information on peer capital raising activities through warrant conversion is not provided in the filing. ## Context metrics (time-bound) * **Capital Infusion:** ₹147.05 crore (June 04, 2026) * **Equity Shares Allotted:** 83,43,263 (June 04, 2026) * **Issue Price:** ₹235 per share * **Post-Allotment Paid-up Capital:** ₹341.23 crore * **Total Equity Shares:** 34,12,33,742 ## What to track next Investors will be keen to observe the performance of Religare Enterprises following this capital infusion and the eventual expiry of the lock-in period for the newly allotted shares.
Get stock alerts instantly on WhatsApp
Quarterly results, bulk deals, concall updates and major announcements delivered in real time.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.
